Cigna Group Files 8-K: Material Agreement and Financial Updates
Ticker: CI · Form: 8-K · Filed: 2025-09-04T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, financial-obligation
Related Tickers: CI
TL;DR
Cigna Group signed a big deal, expect financial shifts.
AI Summary
On September 4, 2025, The Cigna Group entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The report covers other events and includes financial statements and exhibits.
Why It Matters
This filing signals a significant new agreement for Cigna Group, potentially impacting its financial obligations and future business operations.
Risk Assessment
Risk Level: medium — Material definitive agreements and new financial obligations can introduce significant business and financial risks.
Key Players & Entities
- The Cigna Group (company) — Registrant
- September 4, 2025 (date) — Date of Report
FAQ
What type of material definitive agreement did The Cigna Group enter into?
The filing states that The Cigna Group entered into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What is the nature of the financial obligation created by this filing?
The filing indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant, but the specifics are not detailed in the provided text.
When was this 8-K filing submitted?
This 8-K filing was submitted on September 4, 2025.
What is the principal executive office address for The Cigna Group?
The principal executive offices of The Cigna Group are located at 900 Cottage Grove Road, Bloomfield, Connecticut 06002.
What is the IRS Employer Identification Number for The Cigna Group?
The IRS Employer Identification Number for The Cigna Group is 82-4991898.
From the Filing
0001140361-25-033986.txt : 20250904 0001140361-25-033986.hdr.sgml : 20250904 20250904160806 ACCESSION NUMBER: 0001140361-25-033986 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250904 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250904 DATE AS OF CHANGE: 20250904 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 251293449 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 ny20054607x5_8k.htm 8-K false Cigna Group 0001739940 900 COTTAGE GROVE ROAD BLOOMFIELD NYSE 0001739940 2025-09-04 2025-09-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 4, 2025 The Cigna Group (Exact name of registrant as specified in its charter) Delaware 001-38769 82-4991898 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 900 Cottage Grove Road Bloomfield , Connecticut 06002 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 860 ) 226-6000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Item 1.01  Entry into a Material Definitive Agreement. On September 4, 2025, The Cigna Group (the “Company”) completed its offering of $1,000,000,000 in aggregate principal amount of its 4.500% Senior Notes due 2030 (the “2030 Notes”), $1,250,000,000 in aggregate principal amount of its 4.875% Senior Notes due 2032 (the “2032 Notes”), $1,500,000,000 in aggregate principal amount of its 5.250% Senior Notes due 2036 (the “2036 Notes”) and $750,000,000 in aggregate principal amo